Advanced search
Publication Cover
OncoImmunology Volume 6, 2017 - Issue 7
Submit an article Journal homepage
1,523
Views
39
CrossRef citations to date
0
Altmetric
Miata Compliant Research Paper

NK cell dysfunction in chronic lymphocytic leukemia is associated with loss of the mature cells expressing inhibitory killer cell Ig-like receptors

Alexander W. MacFarlane IVBlood Cell Development and Function Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USA
,
Mowafaq JillabBlood Cell Development and Function Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USA;Department of Pathology, Fox Chase Cancer Center, Philadelphia, PA, USA
,
Mitchell R. SmithDepartment of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA
,
R. Katherine AlpaughDepartment of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USAORCID Iconhttp://orcid.org/0000-0002-6775-5323
ORCID Icon,
Marion E. ColeDepartment of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA
,
Samuel LitwinBioinformatics and Biostatistics Facility, Fox Chase Cancer Center, Philadelphia, PA, USA
,
Michael M. MillensonDepartment of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA
,
Tahseen Al-SaleemDepartment of Pathology, Fox Chase Cancer Center, Philadelphia, PA, USA
,
Adam D. CohenDepartment of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USACorrespondence[email protected]
&
Kerry S. CampbellBlood Cell Development and Function Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USACorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0003-4665-7326
ORCID Icon show all
Article: e1330235 | Received 13 Dec 2016, Accepted 09 May 2017, Published online: 20 Jun 2017

Citations (39)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Dhon Roméo Makanga, Maxime Jullien, Gaëlle David, Nolwenn Legrand, Catherine Willem, Léa Dubreuil, Alexandre Walencik, Cyrille Touzeau, Thomas Gastinne, Benoit Tessoulin, Steven Le Gouill, Béatrice Mahé, Katia Gagne, Patrice Chevallier, Béatrice Clemenceau & Christelle Retière. (2021) Low number of KIR ligands in lymphoma patients favors a good rituximab-dependent NK cell response. OncoImmunology 10:1.
Read now

Articles from other publishers (38)

Baustin M. Welch, Bryce A. Manso, Kimberly A. Gwin, Petra K. Lothert, Sameer A. Parikh, Neil E. Kay & Kay L. Medina. (2023) Comparison of the blood immune repertoire with clinical features in chronic lymphocytic leukemia patients treated with chemoimmunotherapy or ibrutinib. Frontiers in Oncology 13.
Crossref
Jack G. Fisher, Amber D. P. Doyle, Lara V. Graham, Shreyanshi Sonar, Ben Sale, Isla Henderson, Luis Del Rio, Peter W. M. Johnson, Yosef Landesman, Mark S. Cragg, Francesco Forconi, Christopher J. Walker, Salim. I. Khakoo & Matthew D. Blunt. (2023) XPO1 inhibition sensitises CLL cells to NK cell mediated cytotoxicity and overcomes HLA-E expression. Leukemia.
Crossref
Yanlin Yu. (2023) The Function of NK Cells in Tumor Metastasis and NK Cell-Based Immunotherapy. Cancers 15:8, pages 2323.
Crossref
Mihaela Andreescu, Nicoleta Berbec & Alina Daniela Tanase. (2023) Assessment of Impact of Human Leukocyte Antigen-Type and Cytokine-Type Responses on Outcomes after Targeted Therapy Currently Used to Treat Chronic Lymphocytic Leukemia. Journal of Clinical Medicine 12:7, pages 2731.
Crossref
Abdurraouf Mokhtar Mahmoud, Gianluca Gaidano & Samir Mouhssine. (2023) Immunological Aspects of Richter Syndrome: From Immune Dysfunction to Immunotherapy. Cancers 15:4, pages 1015.
Crossref
Jack Fisher, Amber Doyle, Lara Graham, Salim Khakoo & Matthew Blunt. (2022) Disruption of the NKG2A:HLA-E Immune Checkpoint Axis to Enhance NK Cell Activation against Cancer. Vaccines 10:12, pages 1993.
Crossref
Loubna Oumeslakht, Abdel-ilah Aziz, Armand Bensussan & Sanae Ben Mkaddem. (2022) CD160 receptor in CLL: Current state and future avenues. Frontiers in Immunology 13.
Crossref
Max Yano, Chia Sharpe, J. Rachel Lance, Janani Ravikrishnan, Kevan Zapolnik, Xiaokui Mo, Jennifer A. Woyach, Deepa Sampath, Adam S. Kittai, Sumithira Vasu, Seema Bhat, Kerry A. Rogers, Dean A. Lee, Natarajan Muthusamy & John C. Byrd. (2022) Evaluation of allogeneic and autologous membrane-bound IL-21–expanded NK cells for chronic lymphocytic leukemia therapy. Blood Advances 6:20, pages 5641-5654.
Crossref
Nicholas A. Maskalenko, Dmitry Zhigarev & Kerry S. Campbell. (2022) Harnessing natural killer cells for cancer immunotherapy: dispatching the first responders. Nature Reviews Drug Discovery 21:8, pages 559-577.
Crossref
Dmitry Zhigarev, Asya Varshavsky, Alexander W. MacFarlaneIVIV, Prathiba Jayaguru, Laura Barreyro, Marina Khoreva, Essel Dulaimi, Reza Nejati, Christina Drenberg & Kerry S. Campbell. (2022) Lymphocyte Exhaustion in AML Patients and Impacts of HMA/Venetoclax or Intensive Chemotherapy on Their Biology. Cancers 14:14, pages 3352.
Crossref
Genelle F. Harrison, Laura Ann Leaton, Erica A. Harrison, Katherine M. Kichula, Marte K. Viken, Jonathan Shortt, Christopher R. Gignoux, Benedicte A. Lie, Damjan Vukcevic, Stephen Leslie & Paul J. Norman. (2022) Allele imputation for the killer cell immunoglobulin-like receptor KIR3DL1/S1. PLOS Computational Biology 18:2, pages e1009059.
Crossref
Michaela Allison, Joel Mathews, Taylor Gilliland & Stephen O. Mathew. (2022) Natural Killer Cell-Mediated Immunotherapy for Leukemia. Cancers 14:3, pages 843.
Crossref
Anna Puiggros, Gonzalo Blanco, Aura Muntasell, María Rodríguez‐Rivera, Lara Nonell, Mireia Altadill, Eulàlia Puigdecanet, Magdalena Arnal, Xavier Calvo, Eva Gimeno, Eugènia Abella, Pau Abrisqueta, Francesc Bosch, José Yélamos, Ana Ferrer, Miguel López‐Botet & Blanca Espinet. (2021) Reduced expansion of CD94/NKG2C + NK cells in chronic lymphocytic leukemia and CLL‐like monoclonal B‐cell lymphocytosis is not related to increased human cytomegalovirus seronegativity or NKG2C deletions . International Journal of Laboratory Hematology 43:5, pages 1032-1040.
Crossref
Candida Vitale, Elia Boccellato, Lorenzo Comba, Rebecca Jones, Francesca Perutelli, Valentina Griggio & Marta Coscia. (2021) Impact of Immune Parameters and Immune Dysfunctions on the Prognosis of Patients with Chronic Lymphocytic Leukemia. Cancers 13:15, pages 3856.
Crossref
Paolo Sportoletti, Filomena De Falco, Beatrice Del Papa, Stefano Baldoni, Valerio Guarente, Andrea Marra, Erica Dorillo, Chiara Rompietti, Francesco Maria Adamo, Loredana Ruggeri, Mauro Di Ianni & Emanuela Rosati. (2021) NK Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications. International Journal of Molecular Sciences 22:13, pages 6665.
Crossref
Christian Sordo-Bahamonde, Seila Lorenzo-Herrero, Ana P. González-Rodríguez, Ángel R. Payer, Esther González-García, Alejandro López-Soto & Segundo Gonzalez. (2021) LAG-3 Blockade with Relatlimab (BMS-986016) Restores Anti-Leukemic Responses in Chronic Lymphocytic Leukemia. Cancers 13:9, pages 2112.
Crossref
Christian Sordo-Bahamonde, Seila Lorenzo-Herrero, Ana P Gonzalez-Rodriguez, Ángel R. Payer, Esther González-García, Alejandro López-Soto & Segundo Gonzalez. (2021) BTLA/HVEM Axis Induces NK Cell Immunosuppression and Poor Outcome in Chronic Lymphocytic Leukemia. Cancers 13:8, pages 1766.
Crossref
Clifford M. Csizmar & Stephen M. Ansell. (2021) Engaging the Innate and Adaptive Antitumor Immune Response in Lymphoma. International Journal of Molecular Sciences 22:7, pages 3302.
Crossref
Zuzana Mikulkova, Gayane Manukyan, Peter Turcsanyi, Milos Kudelka, Renata Urbanova, Jakub Savara, Eliska Ochodkova, Yvona Brychtova, Jan Molinsky, Martin Simkovic, David Starostka, Jan Novak, Ondrej Janca, Martin Dihel, Pavlina Ryznerova, Lekaa Mohammad, Tomas Papajik & Eva Kriegova. (2021) Deciphering the complex circulating immune cell microenvironment in chronic lymphocytic leukaemia using patient similarity networks. Scientific Reports 11:1.
Crossref
Tatiana Pazina, Alexander W. MacFarlaneIVIV, Luca Bernabei, Essel Dulaimi, Rebecca Kotcher, Clinton Yam, Natalie A. Bezman, Michael D. Robbins, Eric A. Ross, Kerry S. Campbell & Adam D. Cohen. (2021) Alterations of NK Cell Phenotype in the Disease Course of Multiple Myeloma. Cancers 13:2, pages 226.
Crossref
Sandra V. Fernandez, Alexander W. MacFarlaneIVIV, Mowafaq Jillab, Maria F. Arisi, Jennifer Yearley, Lakshmanan Annamalai, Yulan Gong, Kathy Q. Cai, R. Katherine Alpaugh, Massimo Cristofanilli & Kerry S. Campbell. (2020) Immune phenotype of patients with stage IV metastatic inflammatory breast cancer. Breast Cancer Research 22:1.
Crossref
Valentina Griggio, Francesca Perutelli, Chiara Salvetti, Elia Boccellato, Mario Boccadoro, Candida Vitale & Marta Coscia. (2020) Immune Dysfunctions and Immune-Based Therapeutic Interventions in Chronic Lymphocytic Leukemia. Frontiers in Immunology 11.
Crossref
Massimo Giuliani & Alessandro Poggi. (2020) Checkpoint Inhibitors and Engineered Cells: New Weapons for Natural Killer Cell Arsenal Against Hematological Malignancies. Cells 9:7, pages 1578.
Crossref
Maral Hemati, Zahra Rasouli Nejad, Mohammad-Reza Shokri, Farahnaz Ghahremanfard, Majid Mir Mohammadkhani & Parviz Kokhaei. (2020) IL-27 impact on NK cells activity: Implication for a robust anti-tumor response in chronic lymphocytic leukemia. International Immunopharmacology 82, pages 106350.
Crossref
Francesca Arruga, Benjamin Baffour Gyau, Andrea Iannello, Nicoletta Vitale, Tiziana Vaisitti & Silvia Deaglio. (2020) Immune Response Dysfunction in Chronic Lymphocytic Leukemia: Dissecting Molecular Mechanisms and Microenvironmental Conditions. International Journal of Molecular Sciences 21:5, pages 1825.
Crossref
Aviad Ben-Shmuel, Guy Biber & Mira Barda-Saad. (2020) Unleashing Natural Killer Cells in the Tumor Microenvironment–The Next Generation of Immunotherapy?. Frontiers in Immunology 11.
Crossref
Tom Hofland, Sanne Endstra, Calum K.P. Gomes, Renate de Boer, Iris de Weerdt, Vladimir Bobkov, Jurgen A. Riedl, Raimond Heukers, Martine J. Smit, Eric Eldering, Mark-David Levin, Arnon P. Kater & Sanne H. Tonino. (2019) Natural Killer Cell Hypo-responsiveness in Chronic Lymphocytic Leukemia can be Circumvented In Vitro by Adequate Activating Signaling. HemaSphere 3:6, pages e308.
Crossref
Iris de WeerdtTom HoflandRenate de BoerJohan A. Dobber, Julie Dubois, Denise van NieuwenhuizeMehrdad MobasherFransien de BoerMels HoogendoornGerjo A. VeldersMarjolein van der KliftEster B. M. Remmerswaal, Frederike J. BemelmanCarsten U. NiemannSabina KerstingMark-David Levin, Eric Eldering, Sanne H. Tonino & Arnon P. Kater. (2019) Distinct immune composition in lymph node and peripheral blood of CLL patients is reshaped during venetoclax treatment. Blood Advances 3:17, pages 2642-2652.
Crossref
Tom Hofland, Eric Eldering, Arnon P. Kater & Sanne H. Tonino. (2019) Engaging Cytotoxic T and NK Cells for Immunotherapy in Chronic Lymphocytic Leukemia. International Journal of Molecular Sciences 20:17, pages 4315.
Crossref
Mulder, Wahlin, Österborg & Palma. (2019) Targeting the Immune Microenvironment in Lymphomas of B-Cell Origin: From Biology to Clinical Application. Cancers 11:7, pages 915.
Crossref
Veronika Bachanova, Daniel J. Weisdorf, Tao Wang, Steven G.E. Marsh, Nezih Cereb, Michael D. Haagenson, Stephen R. Spellman, Stephanie J. Lee, Lisbeth A. Guethlein, Peter Parham, Jeffrey S. Miller & Sarah A. Cooley. (2019) Donor Killer Cell Immunoglobulin-Like Receptor Genotype Does Not Improve Graft-versus-Leukemia Responses in Chronic Lymphocytic Leukemia after Unrelated Donor Transplant: A Center for International Blood and Marrow Transplant Research Analysis. Biology of Blood and Marrow Transplantation 25:5, pages 949-954.
Crossref
Satyen H. GohilCatherine J. Wu. (2019) Dissecting CLL through high-dimensional single-cell technologies. Blood 133:13, pages 1446-1456.
Crossref
Martin Felices, Behiye Kodal, Peter Hinderlie, Michael F. Kaminski, Sarah Cooley, Daniel J. Weisdorf, Daniel A. Vallera, Jeffrey S. Miller & Veronika Bachanova. (2019) Novel CD19-targeted TriKE restores NK cell function and proliferative capacity in CLL. Blood Advances 3:6, pages 897-907.
Crossref
Leila Hadadi, Morteza Hafezi, Ali Akbar  Amirzargar, Ramazan Ali  Sharifian, Saeid Abediankenari & Hossein Asgarian-Omran. (2019) Dysregulated Expression of Tim-3 and NKp30 Receptors on NK Cells of Patients with Chronic Lymphocytic Leukemia. Oncology Research and Treatment 42:4, pages 197-203.
Crossref
Mónica Villa-Álvarez, Christian Sordo-Bahamonde, Seila Lorenzo-Herrero, Ana P. Gonzalez-Rodriguez, Angel R. Payer, Esther Gonzalez-Garcia, María C. Villa-Álvarez, Alejandro López-Soto & Segundo Gonzalez. (2018) Ig-Like Transcript 2 (ILT2) Blockade and Lenalidomide Restore NK Cell Function in Chronic Lymphocytic Leukemia. Frontiers in Immunology 9.
Crossref
Concepción F. Guillamón, María V. Martínez-Sánchez, Lourdes Gimeno, Anna Mrowiec, Jerónimo Martínez-García, Gerardo Server-Pastor, Jorge Martínez-Escribano, Amparo Torroba, Belén Ferri, Daniel Abellán, José A. Campillo, Isabel Legaz, María R. López-Álvarez, María Rosa Moya-Quiles, Manuel Muro & Alfredo Minguela. (2018) NK Cell Education in Tumor Immune Surveillance: DNAM-1/KIR Receptor Ratios as Predictive Biomarkers for Solid Tumor Outcome. Cancer Immunology Research 6:12, pages 1537-1547.
Crossref
Leonard Angka, Andre B. Martel, Marisa Kilgour, Ahwon Jeong, Manahil Sadiq, Christiano Tanese de Souza, Laura Baker, Michael A. Kennedy, Natasha Kekre & Rebecca C. Auer. (2018) Natural Killer Cell IFNγ Secretion is Profoundly Suppressed Following Colorectal Cancer Surgery. Annals of Surgical Oncology 25:12, pages 3747-3754.
Crossref
Wen-Ting Wang, Hua-Yuan Zhu, Yu-Jie Wu, Yi Xia, Jia-Zhu Wu, Wei Wu, Jin-Hua Liang, Li Wang, Lei Fan, Jian-Yong Li & Wei Xu. (2018) Elevated absolute NK cell counts in peripheral blood predict good prognosis in chronic lymphocytic leukemia. Journal of Cancer Research and Clinical Oncology 144:3, pages 449-457.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.